These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 32320111)
1. Repurposing of respiratory drug theophylline against Candida albicans: mechanistic insights unveil alterations in membrane properties and metabolic fitness. Singh S; Fatima Z; Ahmad K; Hameed S J Appl Microbiol; 2020 Oct; 129(4):860-875. PubMed ID: 32320111 [TBL] [Abstract][Full Text] [Related]
2. Magnesium deprivation affects cellular circuitry involved in drug resistance and virulence in Candida albicans. Hans S; Fatima Z; Hameed S J Glob Antimicrob Resist; 2019 Jun; 17():263-275. PubMed ID: 30659981 [TBL] [Abstract][Full Text] [Related]
3. Mechanistic insights into antifungal potential of Alexidine dihydrochloride and hexachlorophene in Candida albicans: a drug repurposing approach. Ansari A; Kumar D; Gupta P; Poluri KM; Rai N; Ameen F; Kumar N Arch Microbiol; 2024 Aug; 206(9):383. PubMed ID: 39162873 [TBL] [Abstract][Full Text] [Related]
4. Octyl gallate triggers dysfunctional mitochondria leading to ROS driven membrane damage and metabolic inflexibility along with attenuated virulence in Candida albicans. Saibabu V; Fatima Z; Ahmad K; Khan LA; Hameed S Med Mycol; 2020 Apr; 58(3):380-392. PubMed ID: 31135913 [TBL] [Abstract][Full Text] [Related]
5. Repurposing the anthelminthic salicylanilide oxyclozanide against susceptible and clinical resistant Candida albicans strains. Pic E; Burgain A; Sellam A Med Mycol; 2019 Apr; 57(3):387-390. PubMed ID: 29762783 [TBL] [Abstract][Full Text] [Related]
6. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms. Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780 [TBL] [Abstract][Full Text] [Related]
7. Otilonium Bromide Exhibits Potent Antifungal Effects by Blocking Ergosterol Plasma Membrane Localization and Triggering Cytotoxic Autophagy in Candida Albicans. Zhen C; Wang L; Feng Y; Whiteway M; Hang S; Yu J; Lu H; Jiang Y Adv Sci (Weinh); 2024 Sep; 11(35):e2406473. PubMed ID: 38995235 [TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans. de Sá NP; de Paula LFJ; Lopes LFF; Cruz LIB; Matos TTS; Lino CI; de Oliveira RB; de Souza-Fagundes EM; Fuchs BB; Mylonakis E; Johann S J Glob Antimicrob Resist; 2018 Sep; 14():287-293. PubMed ID: 29715565 [TBL] [Abstract][Full Text] [Related]
9. D319 induced antifungal effects through ROS-mediated apoptosis and inhibited isocitrate lyase in Candida albicans. Ding Y; Zhang K; Yin Y; Wu J Biochim Biophys Acta Gen Subj; 2022 Feb; 1866(2):130050. PubMed ID: 34800580 [TBL] [Abstract][Full Text] [Related]
10. Insights on the anticandidal activity of non-antifungal drugs. Moraes DC; Ferreira-Pereira A J Mycol Med; 2019 Sep; 29(3):253-259. PubMed ID: 31399349 [TBL] [Abstract][Full Text] [Related]
11. Repurposing of Fluvastatin Against Candida albicans CYP450 Lanosterol 14 α-demethylase, a Target Enzyme for Antifungal Therapy: An In silico and In vitro Study. Rana R; Sharma R; Kumar A Curr Mol Med; 2019; 19(7):506-524. PubMed ID: 31109273 [TBL] [Abstract][Full Text] [Related]
12. Antifungal Activity Directed Toward the Cell Wall by 2-Cyclohexylidenhydrazo- 4-Phenyl-Thiazole Against Candida albicans. de Sá NP; Pôssa AP; Perez P; Ferreira JMS; Fonseca NC; Lino CI; Cruz LB; de Oliveira RB; Rosa CA; Borelli BM; Mylonakis E; Fuchs BB; Johann S Infect Disord Drug Targets; 2019; 19(4):428-438. PubMed ID: 29852876 [TBL] [Abstract][Full Text] [Related]
13. Virtual screening and drug repositioning as strategies for the discovery of new antifungal inhibitors of oxidosqualene cyclase. Rabelo VW; Viegas DJ; Tucci EMN; Romeiro NC; Abreu PA J Steroid Biochem Mol Biol; 2019 Jan; 185():189-199. PubMed ID: 30193921 [TBL] [Abstract][Full Text] [Related]
14. Punicalagin triggers ergosterol biosynthesis disruption and cell cycle arrest in Cryptococcus gattii and Candida albicans : Action mechanisms of punicalagin against yeasts. Silva TC; de Ávila RI; Zara ALSA; Santos AS; Ataídes F; Freitas VAQ; Costa CR; Valadares MC; Silva MDRR Braz J Microbiol; 2020 Dec; 51(4):1719-1727. PubMed ID: 32856241 [TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agents. Cheah HL; Lim V; Sandai D PLoS One; 2014; 9(4):e95951. PubMed ID: 24781056 [TBL] [Abstract][Full Text] [Related]
17. Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi. Wiederhold NP; Patterson TF; Srinivasan A; Chaturvedi AK; Fothergill AW; Wormley FL; Ramasubramanian AK; Lopez-Ribot JL Virulence; 2017 Feb; 8(2):138-142. PubMed ID: 27268469 [TBL] [Abstract][Full Text] [Related]
18. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans. Sun L; Liao K; Hang C Phytomedicine; 2018 Feb; 40():55-58. PubMed ID: 29496175 [TBL] [Abstract][Full Text] [Related]
19. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis. Jafri H; Ahmad I J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964 [TBL] [Abstract][Full Text] [Related]
20. Repurposing of Ribavirin as an Adjunct Therapy against Invasive Yousfi H; Cassagne C; Ranque S; Rolain JM; Bittar F Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]